新型冠状病毒肺炎疫情时期急性卒中绿色通道诊疗优化策略——奥密克戎变异株流行期间的上海经验

doi:10.3969/j.issn.1673-5765.2022.09.020

摘要/Abstract

摘要： 在新型冠状病毒奥密克戎变异株流行的当下，急性卒中的绿色通道诊疗面临了更多挑战。由于奥密克戎变异株具有更高的传播能力且临床表现隐匿，新型冠状病毒肺炎疫情的防治工作难度增加。既往的绿色通道运行策略在当前疫情背景下存在着诸多局限性。结合指南与上海疫情期间的临床实践，本文梳理了包括新型冠状病毒抗原检测、急诊区域管理、医务人员防护等在内的急性卒中绿色通道诊疗优化策略，以期为急性卒中的急救流程管理提供更多参考。

关键词: SARS-CoV-2; 新型冠状病毒肺炎; 卒中

Abstract: With the spreading of Omicron variant of a novel coronavirus (SARS-CoV-2), the workflow of acute ischemic stroke emergency care faced great challenges. The increased transmissibility and the latent manifestations of the Omicron variant, made stroke emergency care more complex in Shanghai. The previous acute stroke in-hospital fast track had several limitations under the epidemic of Omicron variant. Combining the guidelines with clinical practice during the epidemic in Shanghai, this article summaried the optimized acute stroke emergency workflow, including SARS-CoV-2 antigen test, emergency area management and protective measure of medical staff, to provide reference for acute stroke emergency care.

Key words: SARS-CoV-2; COVID-19; Stroke

徐嘉文, 董漪, 王子高, 高超, 倪伟, 姜晓斐, 曹文杰, 程忻, 顾宇翔, 董强. 新型冠状病毒肺炎疫情时期急性卒中绿色通道诊疗优化策略——奥密克戎变异株流行期间的上海经验[J]. 中国卒中杂志, 2022, 17(09): 1031-1036.

XU Jiawen, DONG Yi, WANG Zigao, GAO Chao, NI Wei, JIANG Xiaofei, CAO Wenjie, CHENG Xin, GU Yuxiang, DONG Qiang. Optimization Strategy for Acute Ischemic Stroke Fast Track during the COVID-19 Epidemic: Shanghai Experience during the Epidemic of Omicron Variant[J]. Chinese Journal of Stroke, 2022, 17(09): 1031-1036.

参考文献

[1] 国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案（试行第九版）[J]. 国际流行病学传染病学杂志，2022，49（2）：73-80.
[2] Classification of Omicron（B.1.1.529）：SARS-CoV-2 variant of concern[EB/OL]. （2021-11-26）[2022-06-10]. https://www.who.int/news/item/26-11-2021-classification-of-omicron-（b.1.1.529）-sars-cov-2-variant-of-concern.
[3] MASLO C，FRIEDLAND R，TOUBKIN M，et al. Characteristics and outcomes of hospitalized patients in south Africa during the COVID-19 Omicron wave compared with previous waves[J]. JAMA，2022，327（6）：583-584.
[4] HUI K P Y，HO J C W，CHEUNG M C，et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo[J]. Nature，2022，603（7902）：715-720.
[5] WANG Y J，LI Z X，GU H Q，et al. China stroke statistics 2019：a report from the National Center for Healthcare Quality Management in Neurological Diseases，China National Clinical Research Center for Neurological Diseases，the Chinese Stroke Association，National Center for Chronic and Non-communicable Disease Control and Prevention，Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol，2020，5（3）：211-239.
[6] XIE Y，BOWE B，MADDUKURI G，et al. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza：cohort study[J/OL]. BMJ，2020，371：m4677[2022-06-10]. https://doi.org/10.1136/bmj.m4677.
[7] GUPTA A，MADHAVAN M V，SEHGAL K，et al. Extrapulmonary manifestations of COVID-19[J]. Nat Med，2020，26（7）：1017-1032.
[8] LI Y N，LI M，WANG M D，et al. Acute cerebrovascular disease following COVID-19：a single center，retrospective，observational study[J]. Stroke Vasc Neurol，2020，5（3）：279-284.
[9] TAN Y K，GOH C，LEOW A S T，et al. COVID-19 and ischemic stroke：a systematic review and meta-summary of the literature[J]. J Thromb Thrombolysis，2020，50（3）：587-595.
[10] MODIN D，CLAGGETT B，SINDET-PEDERSEN C，et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction[J]. Circulation，2020，142（21）：2080-2082.
[11] KATSOULARIS I，FONSECA-RODRÍGUEZ O，FARRINGTON P，et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden：a self-controlled case series and matched cohort study[J]. Lancet，2021，398（10300）：599-607.
[12] XIE Y，XU E，BOWE B，et al. Long-term cardiovascular outcomes of COVID-19[J]. Nat Med，2022，28（3）：583-590.
[13] HELMS J，TACQUARD C，SEVERAC F，et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection：a multicenter prospective cohort study[J]. Intensive Care Med，2020，46（6）：1089-1098.
[14] MERKLER A E，PARIKH N S，MIR S，et al. Risk of ischemic stroke in patients with coronavirus disease 2019（COVID-19）vs patients with influenza[J]. JAMA Neurol，2020，77（11）：1-7.
[15] MAGADUM A，KISHORE R. Cardiovascular manifestations of COVID-19 infection[J/OL]. Cells，2020，9（11）：2508[2022-06-10]. https://doi.org/10.3390/cells9112508.
[16] VARGA Z，FLAMMER A J，STEIGER P，et al. Endothelial cell infection and endotheliitis in COVID-19[J]. Lancet，2020，395（10234）：1417-1418.
[17] SONG W C，FITZGERALD G A. COVID-19，microangiopathy，hemostatic activation，and complement[J]. J Clin Invest，2020，130（8）：3950-3953.
[18] DELOREY T M，ZIEGLER C G K，HEIMBERG G，et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets[J]. Nature，2021，595（7865）：107-113.
[19] NISHIGA M，WANG D W，HAN Y，et al. COVID-19 and cardiovascular disease：from basic mechanisms to clinical perspectives[J]. Nat Rev Cardiol，2020，17（9）：543-558.
[20] NOGUEIRA R G，QURESHI M M，ABDALKADER M，et al. Global impact of COVID-19 on stroke care and Ⅳ thrombolysis[J/OL]. Neurology，2021，96（23）：e2824-e2838[2022-06-10]. https://doi.org/10.1212/WNL.0000000000011885.
[21] NOGUEIRA R G，ABDALKADER M，QURESHI M M，et al. Global impact of COVID-19 on stroke care[J]. Int J Stroke，2021，16（5）：573-584.
[22] RISSER C，TRAN BA LOC P，BINDER-FOUCARD F，et al. COVID-19 impact on stroke admissions during France's first epidemic peak：an exhaustive，nationwide，observational study[J]. Cerebrovasc Dis，2022，51（5）：663-669.
[23] ORTEGA-GUTIERREZ S，FAROOQUI M，ZHA A，et al. Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic：the Society of Vascular and Interventional Neurology Multicenter Collaboration[J/OL]. Clin Neurol Neurosurg，2021，201：106436[2022-06-10]. https://doi.org/10.1016/j.clineuro.2020.106436.
[24] BRUNETTI V，BROCCOLINI A，CALIANDRO P，et al. Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network[J]. Neurol Sci，2021，42（4）：1237-1245.
[25] KÄMPFER N A，NALDI A，BRAGAZZI N L，et al. Reorganizing stroke and neurological intensive care during the COVID-19 pandemic in Germany[J/OL]. Acta Biomed，2021，92（5）：e2021266[2022-06-10]. https://doi.org/10.23750/abm.v92i5.10418.
[26] DRENCK N，GRUNDTVIG J，CHRISTENSEN T，et al. Stroke admissions and revascularization treatments in Denmark during COVID-19[J]. Acta Neurol Scand，2022，145（2）：160-170.
[27] 张文宏. 新冠肺炎全球流行背景下我国防控策略的实施[R/OL].（2022-05-23）[2022-06-10]. https://baijiahao.baidu.com/s?id=1733616161492065383&wfr=spider&for=pc.
[28] 国务院联防联控机制2022年3月15日新闻发布会文字实录[EB/OL].（2022-03-15）[2022-06-10]. www.nhc.gov.cn/xcs/s3574/202203/f305418902d44c9891727115d4440f55.shtml.
[29] POWERS W J，RABINSTEIN A A，ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2019，50（12）：e344-e418[2022-06-10]. https://doi.org/10.1161/STR.0000000000000211.
[30] World Health Organization. SARS-CoV-2 antigen-detecting rapid diagnostic tests：an implementation guide[EB/OL]. [2022-09-11]. https://apps.who.int/iris/handle/10665/337948.
[31] HOMZA M，ZELENA H，JANOSEK J，et al. COVID-19 antigen testing：better than we know? A test accuracy study[J]. Infect Dis（Lond），2021，53（9）：661-668.
[32] JEGERLEHNER S，SUTER-RINIKER F，JENT P，et al. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings[J/OL]. Int J Infect Dis，2021，109：118-122[2022-06-10]. https://doi.org/10.1016/j.ijid.2021.07.010.
[33] CIOTTI M，MAURICI M，PIERI M，et al. Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection[J]. J Med Virol，2021，93（5）：2988-2991.
[34] 医疗机构内新型冠状病毒感染预防与控制技术指南（第三版）[J]. 中国农村卫生，2022，14（1）：7-11.
[35] LU S H，TONG X H，HAN Y，et al. Fast and sensitive detection of SARS-CoV-2 RNA using suboptimal protospacer adjacent motifs for Cas12a[J]. Nat Biomed Eng，2022，6（3）：286-297.